Alnylam Pharmaceuticals | ALNY - Stock



Alnylam Pharmaceuticals reported $71.69M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Acadia Pharmaceuticals USD 26.12M 3.18M Jun/2025
Agios Pharmaceuticals USD 30.85M 1.24M Jun/2025
Alnylam Pharmaceuticals USD 71.69M 6.11M Jun/2025
Amgen USD 6.58B 146M Jun/2025
Arrowhead Research USD -173085000 173.08M Dec/2024
BioMarin Pharmaceutical USD 1.34B 65.32M Jun/2025
Incyte USD 83.42M 19.45M Jun/2025
Ionis Pharmaceuticals USD 8.48M 3.02M Jun/2025
Moderna USD 240M 112M Jun/2025
Neurocrine Biosciences USD 56.9M 2.2M Jun/2025
Novartis USD 6.31B 584M Jun/2025
PTC Therapeutics USD 34.06M 12.39M Jun/2025
Regeneron Pharmaceuticals USD 3.21B 760.7M Jun/2025
Sanofi 9.62B 187M Jun/2025
Sarepta Therapeutics USD 994.04M 52.6M Jun/2025
Takeda JPY 1.24T 23.33B Jun/2025
Tectonic Therapeutic USD 0 0 Jun/2020
Ultragenyx Pharmaceutical USD 46.5M 467K Jun/2025
Vertex Pharmaceuticals USD 1.5B 139.6M Jun/2025
Xencor USD 0 0 Jun/2020